{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:07:38Z","timestamp":1777421258518,"version":"3.51.4"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T00:00:00Z","timestamp":1538006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["This study was supported by a Pfizer 2011 GRAND Award"],"award-info":[{"award-number":["This study was supported by a Pfizer 2011 GRAND Award"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0201512","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T13:31:35Z","timestamp":1538055095000},"page":"e0201512","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Testing the PPAR hypothesis of tobacco use disorder in humans: A randomized trial of the impact of gemfibrozil (a partial PPAR\u03b1 agonist) in smokers"],"prefix":"10.1371","volume":"13","author":[{"given":"Marie N. S.","family":"Gendy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Di Ciano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Kowalczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean P.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony P.","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Heishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6406-4973","authenticated-orcid":true,"given":"Bernard","family":"Le Foll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,9,27]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"d4237","DOI":"10.1136\/bmj.d4237","article-title":"WHO urges more countries to adopt large graphic health warnings on tobacco products","volume":"343","author":"J Zarocostas","year":"2011","journal-title":"Bmj"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1146\/annurev.publhealth.29.020907.090934","article-title":"The role of health care systems in increased tobacco cessation","volume":"29","author":"SJ Curry","year":"2008","journal-title":"Annual review of public health"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1176\/appi.ajp.2012.12060793","article-title":"Effect of a nicotine vaccine on nicotine binding to beta2*-nicotinic acetylcholine receptors in vivo in human tobacco smokers","volume":"170","author":"I Esterlis","year":"2013","journal-title":"Am J Psychiatry"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1111\/j.1476-5381.2011.01467.x","article-title":"The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats","volume":"165","author":"M Scherma","year":"2012","journal-title":"British journal of pharmacology"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1124\/jpet.108.142224","article-title":"Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats","volume":"327","author":"M Scherma","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00213-009-1569-5","article-title":"Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration\u2014comparison with CB(1) receptor blockade","volume":"205","author":"B Forget","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1124\/jpet.104.078980","article-title":"Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation","volume":"313","author":"D Fegley","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0092-8674(92)90031-7","article-title":"Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors","volume":"68","author":"C Dreyer","year":"1992","journal-title":"Cell"},{"issue":"7","key":"ref9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.biopsych.2010.07.009","article-title":"Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors","volume":"69","author":"P Mascia","year":"2011","journal-title":"Biological psychiatry"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1038\/npp.2012.31","article-title":"Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings","volume":"37","author":"LV Panlilio","year":"2012","journal-title":"Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology"},{"issue":"Suppl 2","key":"ref11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/00359157760690S227","article-title":"Properties of sterol biosynthesis in human leukocytes: effects of gemfibrozil","volume":"69","author":"DJ Betteridge","year":"1976","journal-title":"Proceedings of the Royal Society of Medicine"},{"issue":"32","key":"ref12","doi-asserted-by":"crossref","first-page":"27189","DOI":"10.1074\/jbc.M112.346932","article-title":"Gemfibrozil, a lipid-lowering drug, induces suppressor of cytokine signaling 3 in glial cells: implications for neurodegenerative disorders","volume":"287","author":"A Ghosh","year":"2012","journal-title":"The Journal of biological chemistry"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1001\/jama.285.12.1585","article-title":"Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial","volume":"285","author":"SJ Robins","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/QAI.0b013e3181b0610e","article-title":"Gemfibrozil concentrations are significantly decreased in the presence of lopinavir-ritonavir","volume":"52","author":"KH Busse","year":"2009","journal-title":"Journal of acquired immune deficiency syndromes"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-199834050-00006","article-title":"Metabolism of fibric acid derivatives","volume":"34","author":"JD Spence","year":"1998","journal-title":"Clin Pharmacokinet"},{"issue":"1\u20132","key":"ref16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejphar.2007.04.017","article-title":"Mitochondria, ciglitazone and liver: a neglected interaction in biochemical pharmacology","volume":"567","author":"R Scatena","year":"2007","journal-title":"European journal of pharmacology"},{"issue":"3\u20134","key":"ref17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s00213-005-0105-5","article-title":"Medication screening for smoking cessation: a proposal for new methodologies","volume":"184","author":"KA Perkins","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/BF00176853","article-title":"Symptoms of tobacco withdrawal from total cigarette cessation versus partial cigarette reduction","volume":"94","author":"DK Hatsukami","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/clpt.2008.30","article-title":"Development of procedures for early screening of smoking cessation medications in humans","volume":"84","author":"KA Perkins","year":"2008","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/clpt.2010.65","article-title":"Cross-validation of a new procedure for early screening of smoking cessation medications in humans","volume":"88","author":"KA Perkins","year":"2010","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/0269881110376694","article-title":"Stress decreases the ability to resist smoking and potentiates smoking intensity and reward","volume":"25","author":"SA McKee","year":"2011","journal-title":"J Psychopharmacol"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/j.1360-0443.2011.03441.x","article-title":"Relative performance of common biochemical indicators in detecting cigarette smoking","volume":"106","author":"GF Marrone","year":"2011","journal-title":"Addiction"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1037\/0022-3514.47.5.1105","article-title":"The independence of positive and negative affect","volume":"47","author":"E Diener","year":"1984","journal-title":"Journal of personality and social psychology"},{"issue":"4","key":"ref24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/14622200801908174","article-title":"Reliability and validity of a Short Form of the Tobacco Craving Questionnaire","volume":"10","author":"SJ Heishman","year":"2008","journal-title":"Nicotine Tob Res"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1037\/a0019401","article-title":"Prolonged duration of craving, mood, and autonomic responses elicited by cues and imagery in smokers: Effects of tobacco deprivation and sex","volume":"18","author":"SJ Heishman","year":"2010","journal-title":"Exp Clin Psychopharmacol"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/tc.7.1.92a","article-title":"Errors in using tobacco withdrawal scale","volume":"7","author":"J Hughes","year":"1998","journal-title":"Tob Control"},{"key":"ref27","first-page":"559","article-title":"Methods of Assessing the Reinforcing Properties of Abused Drugs","author":"H de Wit","year":"1987"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0091-3057(96)00079-2","article-title":"Nicotine preference in smokers as a function of smoking abstinence","volume":"55","author":"KA Perkins","year":"1996","journal-title":"Pharmacology, biochemistry, and behavior"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00213-004-2136-8","article-title":"Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm","volume":"180","author":"M Rukstalis","year":"2005","journal-title":"Psychopharmacology"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.addbeh.2006.06.028","article-title":"Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire","volume":"32","author":"JC Cappelleri","year":"2007","journal-title":"Addictive behaviors"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1037\/0021-843X.106.1.15","article-title":"Induction of smoking urge through imaginal and in vivo procedures: physiological and self-report manifestations","volume":"106","author":"DJ Drobes","year":"1997","journal-title":"J Abnorm Psychol"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1360-0443.1999.9433273.x","article-title":"Meta-analysis of cue-reactivity in addiction research","volume":"94","author":"BL Carter","year":"1999","journal-title":"Addiction"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1037\/0021-843X.103.4.812","article-title":"Effects of cue exposure and deprivation on cognitive resources in smokers","volume":"103","author":"MA Sayette","year":"1994","journal-title":"J Abnorm Psychol"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0306-4603(92)90065-4","article-title":"Smokers' reactions to interpersonal interaction and presentation of smoking cues","volume":"17","author":"R Niaura","year":"1992","journal-title":"Addictive behaviors"},{"issue":"9","key":"ref35","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire","volume":"86","author":"TF Heatherton","year":"1991","journal-title":"Br J Addict"},{"issue":"1","key":"ref36","first-page":"74","article-title":"Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence","volume":"18","author":"KA Perkins","year":"2016","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1360-0443.2004.00540.x","article-title":"Shape of the relapse curve and long-term abstinence among untreated smokers","volume":"99","author":"JR Hughes","year":"2004","journal-title":"Addiction"},{"issue":"7","key":"ref38","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.addbeh.2011.02.011","article-title":"Exposure to smoking cues: cardiovascular and autonomic effects","volume":"36","author":"J Erblich","year":"2011","journal-title":"Addictive behaviors"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1037\/0021-843X.97.2.133","article-title":"Relevance of cue reactivity to understanding alcohol and smoking relapse","volume":"97","author":"RS Niaura","year":"1988","journal-title":"J Abnorm Psychol"},{"issue":"7","key":"ref40","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1360-0443.1992.tb03121.x","article-title":"Increased desire to smoke during acute stress","volume":"87","author":"KA Perkins","year":"1992","journal-title":"Br J Addict"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/0192623314544378","article-title":"Chimeric mice with hepatocyte-humanized liver as an appropriate model to study human peroxisome proliferator-activated receptor-alpha","volume":"43","author":"C Tateno","year":"2015","journal-title":"Toxicol Pathol"},{"issue":"1\u20132","key":"ref42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tox.2009.09.004","article-title":"Microgram-order ammonium perfluorooctanoate may activate mouse peroxisome proliferator-activated receptor alpha, but not human PPARalpha","volume":"265","author":"T Nakamura","year":"2009","journal-title":"Toxicology"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/toxsci\/kfp077","article-title":"Differential hepatic effects of perfluorobutyrate mediated by mouse and human PPAR-alpha","volume":"110","author":"JE Foreman","year":"2009","journal-title":"Toxicol Sci"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuroscience.2003.08.064","article-title":"Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS","volume":"123","author":"S Moreno","year":"2004","journal-title":"Neuroscience"},{"issue":"4","key":"ref45","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1046\/j.1471-4159.1998.70041366.x","article-title":"Distribution of mRNAs encoding the peroxisome proliferator-activated receptor alpha, beta, and gamma and the retinoid X receptor alpha, beta, and gamma in rat central nervous system","volume":"70","author":"TE Cullingford","year":"1998","journal-title":"J Neurochem"},{"issue":"2","key":"ref46","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0090-9556(25)06933-8","article-title":"The metabolism and disposition of fenofibrate in rat, guinea pig, and dog","volume":"16","author":"A Weil","year":"1988","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/acer.12610","article-title":"Peroxisome proliferator-activated receptors alpha and gamma are linked with alcohol consumption in mice and withdrawal and dependence in humans","volume":"39","author":"YA Blednov","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neuropharm.2017.03.005","article-title":"In vivo interactions between alpha7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-alpha: Implication for nicotine dependence","volume":"118","author":"A Jackson","year":"2017","journal-title":"Neuropharmacology"},{"issue":"3","key":"ref49","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/01.ATV.0000154140.73570.00","article-title":"Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation","volume":"25","author":"H Duez","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/jm990554g","article-title":"The PPARs: from orphan receptors to drug discovery","volume":"43","author":"TM Willson","year":"2000","journal-title":"J Med Chem"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0201512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T19:28:28Z","timestamp":1755718108000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0201512"}},"subtitle":[],"editor":[{"given":"Iratxe","family":"Puebla","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,9,27]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0201512","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,27]]}}}